Chlorosibutramine
Chlorosibutramine[edit | edit source]
Chlorosibutramine is a chemical compound that belongs to the class of anorectic agents. It is structurally related to sibutramine, a well-known weight loss medication that was previously used to treat obesity. Chlorosibutramine is characterized by the presence of a chlorine atom in its molecular structure, which differentiates it from its parent compound.
Chemical Properties[edit | edit source]
Chlorosibutramine is a synthetic compound with the chemical formula C17H26ClN. It is a derivative of sibutramine, with a chlorine atom replacing one of the hydrogen atoms in the molecular structure. This modification can affect the compound's pharmacological properties, including its pharmacokinetics and pharmacodynamics.
Mechanism of Action[edit | edit source]
Chlorosibutramine, like sibutramine, is believed to function primarily as a serotonin-norepinephrine reuptake inhibitor (SNRI). This means it inhibits the reuptake of the neurotransmitters serotonin and norepinephrine in the brain, leading to increased levels of these chemicals in the synaptic cleft. The increased availability of serotonin and norepinephrine is thought to contribute to the compound's appetite-suppressing effects.
Clinical Use[edit | edit source]
While sibutramine was used clinically for weight loss, chlorosibutramine has not been widely adopted for medical use. The presence of the chlorine atom may alter its efficacy and safety profile, and further research would be necessary to determine its potential as a therapeutic agent. Sibutramine itself was withdrawn from the market in many countries due to concerns about cardiovascular side effects, which may also be a consideration for chlorosibutramine.
Safety and Side Effects[edit | edit source]
The safety profile of chlorosibutramine is not well-documented, but it may share similar side effects with sibutramine. These could include increased heart rate, elevated blood pressure, and potential cardiovascular risks. As with any pharmacological agent, the risk-benefit ratio must be carefully evaluated before considering its use.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
